Enhanced Solubility of Famotidine through Salification
Open Access
- 22 August 2026
- journal article
- Published by American Chemical Society (ACS) in Crystal Growth & Design
Abstract
Famotidine (FMT) is an active pharmaceutical ingredient that exhibits poor aqueous solubility and poor permeability. Molecular electrostatic potential and pKa calculations were used to guide a salification strategy for FMT and afforded five salts featuring carboxylic acid-containing coformers. All solids feature charge-assisted hydrogen bonds between the guanidinium group of FMT and carboxylate of the coformer. All salts exhibited good thermal and benchtop stability, and a six- to 20-fold increase in aqueous solubility was achieved, depending on the coformer used. The best performing salts include coformers on the FDA’s generally recognized as safe list, making the solids promising for pharmaceutical applications.Keywords
Funding Information
- University of Missouri
- National Institutes of Health (R35GM160214)
This publication has 48 references indexed in Scilit:
- Insoluble drug delivery strategies: review of recent advances and business prospectsActa Pharmaceutica Sinica B, 2015
- Solid-State Supramolecular Synthesis Based on the N–H…O Heterosynthon: An Approach to Solve the Polymorphism Problem in FamotidineJournal of Pharmaceutical Sciences, 2014
- An Overview of Famotidine Polymorphs: Solid-State Characteristics, Thermodynamics, Polymorphic Transformation and Quality ControlPharmaceutical Research, 2014
- Enhancement of the Aqueous Solubility and Masking the Bitter Taste of Famotidine Using Drug/SBE-β-CyD/Povidone K30 Complexation ApproachJournal of Pharmaceutical Sciences, 2010
- Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitisClinical Therapeutics, 1995
- High quality molecular electrostatic potentials from AM1 calculationsJournal of Molecular Graphics, 1993
- Semiempirical AM1 electrostatic potentials and AM1 electrostatic potential derived charges: A comparison with ab initio valuesJournal of Computational Chemistry, 1990
- Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healingGastroenterology, 1989
- Famotidine: An appraisal of its mode of action and safetyThe American Journal of Medicine, 1986
- Famotidine in the therapy of gastric hypersecretory statesThe American Journal of Medicine, 1986